Showing results (121-130 of 532) with videos related to

Sort By:
Pageof 54
The Annals of Pharmacotherapy|January 7, 1999
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic optionsM E Klepser, R E Lewis, M A Pfaller
Journal of Clinical Microbiology|September 1, 1994
Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazoleD L Sewell, M A Pfaller, A L Barry
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformansM E Klepser, E J Wolfe, M A Pfaller
The Journal of Hospital Infection|July 1, 1994
PCR based fingerprinting of Enterobacter cloacaeU N Riain, M G Cormican, J Flynn, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1996
Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalisM G Cormican, M E Erwin, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)M A Pfaller, R N Jones, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|March 8, 2000
In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methodsR E Lewis, M E Klepser, M A Pfaller
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patientsM Bale, M Sanford, R Hollis, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1994
Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniaeM A Pfaller, S A Messer, R J Hollis
Pageof 54